Legal Opinion

In re Pradaxa (Dabigatran Etexilate) Products Liability Litigation

United States Judicial Panel on Multidistrict Litigation

Decided August 8, 2012No. MDL No. 2385PublishedCited by 2 opinions

1Opinion of the Court

TRANSFER ORDER

JOHN G. HEYBURN II, Chairman.

Before the Panel:* Pursuant to 28 U.S.C. § 1407, plaintiff in the Southern District of Illinois Sellers action moves to centralize this litigation in the Southern District of Illinois. This litigation currently consists of twenty-one actions pending in eleven district courts, as listed on Schedule A.1

All the responding parties support centralization, but disagree as to the location of the transferee district. Plaintiffs in eight other actions pending in the Southern District of Illinois (four on the motion and four potential tag-along actions) and…

2Cases cited1 opinion

  1. In Re Yasmin & Yaz (Drospirenone) Marketing, Sales Practices & Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2009

3Cited by2 opinions

  1. In re Xarelto (Rivaroxaban) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2014
  2. Knight v. Boehringer Ingelheim Pharm., Inc.United States District Court · 2018

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API